Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun 30;74(1):74-85.
doi: 10.1016/j.bcp.2007.03.030. Epub 2007 Apr 4.

Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution

Affiliations

Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution

L C Freeman et al. Biochem Pharmacol. .

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) contribute to gastrointestinal ulcer formation by inhibiting epithelial cell migration and mucosal restitution; however, the drug-affected signaling pathways are poorly defined. We investigated whether NSAID inhibition of intestinal epithelial migration is associated with depletion of intracellular polyamines, depolarization of membrane potential (E(m)) and altered surface expression of K(+) channels. Epithelial cell migration in response to the wounding of confluent IEC-6 and IEC-Cdx2 monolayers was reduced by indomethacin (100 microM), phenylbutazone (100 microM) and NS-398 (100 microM) but not by SC-560 (1 microM). NSAID-inhibition of intestinal cell migration was not associated with depletion of intracellular polyamines. Treatment of IEC-6 and IEC-Cdx2 cells with indomethacin, phenylbutazone and NS-398 induced significant depolarization of E(m), whereas treatment with SC-560 had no effect on E(m). The E(m) of IEC-Cdx2 cells was: -38.5+/-1.8 mV under control conditions; -35.9+/-1.6 mV after treatment with SC-560; -18.8+/-1.2 mV after treatment with indomethacin; and -23.7+/-1.4 mV after treatment with NS-398. Whereas SC-560 had no significant effects on the total cellular expression of K(v)1.4 channel protein, indomethacin and NS-398 decreased not only the total cellular expression of K(v)1.4, but also the cell surface expression of both K(v)1.4 and K(v)1.6 channel subunits in IEC-Cdx2. Both K(v)1.4 and K(v)1.6 channel proteins were immunoprecipitated by K(v)1.4 antibody from IEC-Cdx2 lysates, indicating that these subunits co-assemble to form heteromeric K(v) channels. These results suggest that NSAID inhibition of epithelial cell migration is independent of polyamine-depletion, and is associated with depolarization of E(m) and decreased surface expression of heteromeric K(v)1 channels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IEC-6 migration in monolayers grown in the absence (Con) or presence of NSAIDs. Drug-treated cells were exposed to either indomethacin (Indo, 100 μM) or SC-560 (1 μM) for 72 h before a defect was created in the monolayer (wounding). Images were captured immediately (0 h) or 4 h after wounding.
Figure 2
Figure 2
Epithelial cell migration in IEC-6 (panel A) and IEC-Cdx2 (panel B) monolayers (n=6 per group) under control conditions (Con), after depletion of polyamines (DFMO, 5.0 mM), or after treatment with the NSAIDs indomethacin (Indo, 100 μM), phenylbutazone (PBZ, 100 μM), SC-560 (1 μM) and NS-398 (100 μM1). Monolayer cultures were exposed to drug for 72 h before wounding. Migration was measured 4 h post-wounding as the maximum linear distance from the created defect. Asterisks indicate significant difference from control (p < 0.05).
Figure 3
Figure 3
Cellular polyamine concentrations of IEC-6 exposed to NSAIDs. Panel A: Polyamine content of IEC-6 cells treated with DFMO (5 mM) in the absence and presence of exogenous spermadine (SPD, 5 μM). Panel B: IEC-6 treated with indomethacin (Indo, 100 μM), phenylbutazone (PBZ, 100 μM), SC-560 (1 μM) and NS-398 (100 μM). Cellular polyamine concentrations were measured by LC-MS at 78 h post-treatment (n= 3). Asterisks indicate significant difference from control (p < 0.05).
Figure 4
Figure 4
Relative Em of IEC-6 (panel A) and IEC-Cdx2 (panel B) cells under control conditions (Con, n=86), after depletion of polyamines (DFMO, 5.0 mM, n=22 ), or after 72 h treatment with the NSAIDs indomethacin (Indo, 100 μM, n=23), phenylbutazone (PBZ, 100 μM, n=39), SC-560 (1 μM, n=44) and NS-398 (100 μM, n=22). Treatment-induced changes in Em were detected by monitoring the fluorescence of cells loaded with DiBAC4(3). Increased fluorescence indicates depolarization of Em. Different superscripts indicate significant difference between groups (p < 0.05).
Figure 5
Figure 5
Effect of AVE0018 on epithelial cell migration in IEC-Cdx2 cells. Photomicrographs show control (left column) and drug-treated (right column) monolayers immediately (top row) and 4 h (lower row) after wounding. In the graph, epithelial migration is expressed as the percentage of a defined region adjacent to the defect that was occupied by migrating cells 4 h after monolayer wounding in the absence (Con, n=6) and presence of the Kv channel antagonist AVE0118 (1 μM, n=6). Asterisk indicates significant difference (p < 0.05).
Figure 6
Figure 6
Kv1 channel expression by IEC-Cdx2 cells. Immunblots of Kv1.5, Kv1.4 and Kv1.6 channel protein in total cell lysates (Lys), non-biotinylated (NB) and biotinylated (B) fractions obtained from IEC-Cdx2 cells subjected to cell surface biotinylation. After detection of Kv channel protein (upper panel of each set), each blot was stripped and reprobed with antibody against actin to assess loading (lower panel of each set). The apparent molecular masses of Kv1.5, Kv1.4 and Kv1.6 were ~75 kDa, ~96 kDa and ~56 kDa, respectively. The immunoblots shown are representative of n ≥ 3.
Figure 7
Figure 7
Co-association of Kv1.6 and Kv1.4 in IEC-Cdx2. Top: Immunoprecipitation (IP) was performed with antibody against Kv1.4, then the starting material (lane 1), IP (lane 2) and supernatant (lane 3) were immunoblotted (IB) directly with antibody against Kv1.6. Middle: IP was performed with antibody against Kv1.4, then the starting material (lane 1), IP (lane 2) and supernatant (lane 3) were IB with antibody against Kv1.6 pre-incubated with an excess of the fusion protein encoding the epitope used to generate the Kv1.6 antibody. Bottom: IP was performed with antibody against Kv10.1, then the starting material (lane 1), IP (lane 2) and supernatant (lane 3) were IB directly with antibody against Kv1.6. The immunoblots shown are representative of n ≥ 3.
Figure 8
Figure 8
NSAIDs influence the total (panel A), cell surface (panel B) and non-surface (panel C) expression of Kv1.4 by IEC-Cdx2. Monolayer cultures were exposed to drug for 72 h before surface biotinylation and lysis. Drug concentrations were identical to those used in Figures 1–4. Asterisks indicate significant differences (p < 0.05).
Figure 9
Figure 9
The NSAIDs that impair cell migration do not affect the total expression (panel A) of Kv1.6 by IEC-Cdx2; however, these drugs do diminish the cell surface expression (panel B) and increase the non-surface expression (panel C) of Kv1.6. Monolayer cultures were exposed to drug for 72 h before surface biotinylation and lysis. Drug concentrations were identical to those used in Figures 1–4. Asterisks indicate significant differences (p < 0.05).

Similar articles

Cited by

References

    1. Israel LH, Koea JB, Stewart ID, Wright CL, Frankish PD. Nonsteroidal anti-inflammatory drug-induced strictures of the colon: report of a case and review of the literature. Dis Colon Rectum. 2001;44:1362–1364. - PubMed
    1. Karcher LF, Dill SG, Anderson WI, King JM. Right dorsal colitis. J Vet Intern Med. 1990;4:247–253. - PubMed
    1. Lichtenberger LM. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited Biochem Pharmacol. 2001;61:631–637. - PubMed
    1. MacAllister CG, Morgan SJ, Borne AT, Pollet RA. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc. 1993;202:71–77. - PubMed
    1. Whittle BJ. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol. 2003;17:301–313. - PubMed

Publication types

MeSH terms